TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

The Nominees for Best Biopharma CEO of 2015 Are...

  • By Adam Feuerstein
  • Dec 15, 2015 8:14 AM EST
JPMorgan’s Top 4 Oversold Pharma Stocks for Patient Investors
OPINION

Jim Cramer -- Valeant's Sales Struggles Mean Allergan Could Profit

  • By Bret Kenwell
  • Nov 17, 2015 10:49 AM EST
Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
MERGERS AND ACQUISITIONS

Pfizer's Bid for Allergan May Be Too Good to Turn Down

  • By Scott Stuart
  • Oct 29, 2015 5:56 PM EDT
Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back
INVESTING

Allergan Beats Earnings, Delays Forecast Until Next Quarter

  • By TheStreet
  • Aug 6, 2015 2:25 PM EDT
Allergan Beats Estimates, Company to Update Guidance Next Quarter
VIDEO

Allergan Beats Estimates, Company to Update Guidance Next Quarter

  • By TheStreet Staff
  • Aug 6, 2015 12:29 PM EDT
Where Donald Trump Is Spending His Campaign Funds (Hint: His Bodyguard Really Likes McDonald’s)
INVESTING

What to Watch Thursday -- Trump, Bush, Allergan Earnings, Jobless Claims

  • By U-Jin Lee
  • Aug 5, 2015 8:15 PM EDT
Univar to Buy Nexeo for $2 Billion
OPINION

10 Best Biotech Stocks in the NASDAQ

  • By Jon Kostakopoulos
  • Jul 1, 2015 11:23 AM EDT
Jim Cramer's Top Takeaways: The Rubicon Project, GameStop, Delta Air Lines, Alcoa
OPINION

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

  • By Margo Beller
  • Jun 19, 2015 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally Today

  • By Bret Kenwell
  • Jun 18, 2015 8:49 PM EDT
Jim Cramer's Top Takeaways: Luxoft, Nordstrom, Domino's, Honeywell
OPINION

Jim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, Alkermes

  • By Margo Beller
  • Jun 18, 2015 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen

  • By Chris Sahl
  • Jun 17, 2015 8:43 PM EDT
February 27 Premarket Briefing: 10 Things You Should Know
MARKETS

Stocks Climb as Fed Meeting Suggests 2015 Hikes

  • By Keris Alison Lahiff
  • Jun 17, 2015 4:11 PM EDT
J.C. Penney Announces Leadership Changes, Stock Edges Higher
OPINION

5 Stocks on Traders' Radars -- and What You Should Do With Them

  • By Jonas Elmerraji
  • Jun 17, 2015 2:53 PM EDT
Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Recover; Yellen Sees Residual Weakness in Labor Market

  • By Keris Alison Lahiff
  • Jun 17, 2015 2:42 PM EDT
Stocks Fluctuate as Oil Pares Losses, Greek Talks Continue
MARKETS

Crude Oil Boosts Stocks as Domestic Inventories Fall

  • By Keris Alison Lahiff
  • Jun 17, 2015 10:59 AM EDT
Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back
OPINION

Jim Cramer -- Let's Face It, Allergan's Kythera Acquisition Is 'Brilliant'

  • By Bret Kenwell
  • Jun 17, 2015 10:49 AM EDT
NewLink Genetics (NLNK) Upgraded From Sell to Hold
MARKETS

Kythera Biopharma (KYTH) Stock Soaring; Jim Cramer Calls Allergan Deal 'Brilliant'

  • By Kurumi Fukushima
  • Jun 17, 2015 9:32 AM EDT
Stocks Are Slightly Lower as First-Quarter GDP, Chicago PMI Decline
MARKETS

Stock Futures Are Mixed as Investors Await Fed Announcement

  • By Keris Alison Lahiff
  • Jun 17, 2015 8:33 AM EDT
Jim Cramer Says PepsiCo (PEP) is Best Consumer Packaged Goods Company in the World
MARKETS

Allergan (AGN) Stock May Trade Higher; Jim Cramer Calls Kythera Acquisition 'Brilliant'

  • By Kurumi Fukushima
  • Jun 17, 2015 8:26 AM EDT
'Mad Money' Lightning Round: Take Intuit Over H&R Block
JIM CRAMER

'Mad Money' Lightning Round: DreamWorks Animation Is Dead Money

  • By Scott Rutt
  • Jun 11, 2015 11:49 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: There Was Good News Out There Today

  • By Scott Rutt
  • Jun 10, 2015 8:25 PM EDT
Exact Sciences in Talks to Buy Genomic Health - Report
OPINION

Jim Cramer -- Kythera Biopharmaceuticals Is Proving the Bears Wrong

  • By Bret Kenwell
  • Jun 10, 2015 11:13 AM EDT
'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: Sell, Sell, Sell Protein Design Labs

  • By Scott Rutt
  • May 22, 2015 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Snap Judgments Will Cost You

  • By Scott Rutt
  • May 21, 2015 8:27 PM EDT
Inovio Stock Rises on Positive Results From Ebola Vaccine Tests
INVESTING

Kythera CEO Sees Big Profits in Double Chins

  • By Gregg Greenberg
  • May 19, 2015 12:03 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.